Sanofi News - SAN

Kaufen
Verkaufen
Best deals to access real time data!
Euronext
Monthly Subscription
for only
11,81 €
Euronext Level 2
Monthly Subscription
for only
22,17 €
GOLD TRADER
Monthly Subscription
for only
121,88 €
VAT not included
Name Symbol Markt Aktientyp ISIN Beschreibung
Sanofi SAN Euronext Common Stock FR0000120578
  Änderung Änderung % Aktuell Hoch Niedrig Handelsbeginn Handelsende Zeit
  0,00 0,00% 75,98 76,40 75,37 75,68 75,98 17:40:00
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
09.6.201919:01GLOBESoliqua® Phase 3 results significantly lowered blood sugar..
09.6.201919:00ONELes résultats de phase III de Soliqua® montrent une baisse..
09.6.201919:00ONESoliqua® Phase 3 results significantly lowered blood sugar..
07.6.201920:48DJNSanofi on Track for Largest Percent Increase Since October..
07.6.201913:44DJNSanofi Shares Post Healthy Gains After New CEO News
07.6.201908:23DJNSanofi CEO Olivier Brandicourt Retires; Paul Hudson Named..
07.6.201907:50DJNSanofi Appoints New CEO
07.6.201907:01GLOBEPaul Hudson to succeed Olivier Brandicourt as Chief..
07.6.201907:00ONEPaul Hudson to succeed Olivier Brandicourt as Chief..
07.6.201907:00ONEPaul Hudson succèdera à Olivier Brandicourt comme Directeur..
07.6.201901:12DJNSanofi Poised to Appoint Novartis' Paul Hudson as Next CEO..
02.6.201916:46GLOBEPhase 3 trial of isatuximab combination therapy showed 40%..
02.6.201916:45ONEL'essai de phase III de l'isatuximab combiné au pomalidomide..
02.6.201916:45ONEPhase 3 trial of isatuximab combination therapy showed 40%..
22.5.201909:02DJNFrench Deal Spree Fueled By Easy Money -- WSJ
21.5.201920:23ONEInformation concerning the total number of voting rights and..
21.5.201920:23ONEInformations relatives au nombre total de droits de vote et..
21.5.201911:59DJNFrance Goes on Deal Spree, Thanks to ECB Easy Money
07.5.201915:39DJNEU Approves Sanofi and Regeneron's Dupixent for Severe..
07.5.201915:01GLOBESanofi : Dupixent® (dupilumab) Approved for Severe Asthma by..
07.5.201915:00ONESanofi : Dupixent® (dupilumab) Approved for Severe Asthma by..
07.5.201915:00ONESanofi : Dupixent® (dupilumab) approuvé dans le traitement..
02.5.201904:16DJNSanofi's Dengue Vaccine Gets FDA Approval -- Update
02.5.201901:38DJNFDA Approves Sanofi Inc.'s Dengue Vaccine
30.4.201918:01GLOBESanofi: Annual General Meeting of April 30, 2019
30.4.201918:00ONESanofi: Annual General Meeting of April 30, 2019
30.4.201918:00ONESanofi : Assemblée Générale Annuelle du 30 avril 2019
29.4.201917:40DJNLexicon Pharmaceuticals Up 7% After EU Approval for Diabetes..
29.4.201916:46DJNNegative Yields Deepen Along With Europe's Problems--Update
27.4.201902:29DJNFDA Approves Expanded Label for Praluent
27.4.201901:21GLOBESanofi: FDA approves Praluent® (alirocumab) to prevent heart..
27.4.201901:20ONESanofi: FDA approves Praluent® (alirocumab) to prevent heart..
27.4.201901:20ONESanofi : La FDA approuve Praluent® (alirocumab) dans la..
26.4.201923:21DJNEuropean Health Regulators Approve Oral Treatment for Type 1..
26.4.201922:01GLOBEZynquistaTM now approved in the European Union for treatment..
26.4.201922:00ONEZynquistaTM now approved in the European Union for treatment..
26.4.201922:00ONEZynquistaTM désormais approuvé dans l'Union européenne pour..
26.4.201918:48DJNRegeneron, Sanofi Skin Cancer Drug Gets Warm Reception from..
26.4.201917:16GLOBECHMP issues positive opinion for Libtayo® (cemiplimab) in..
26.4.201917:15ONECHMP issues positive opinion for Libtayo® (cemiplimab) in..
26.4.201917:15ONELe CHMP délivre un avis favorable pour Libtayo® (cemiplimab)..
26.4.201914:19DJNDrugmakers Brace for Sales to Slow in China Amid Generic..
26.4.201910:52DJNSanofi Shares Rise on Strong 1Q -- Update
26.4.201908:05DJNSanofi Posts Rises in 1Q Sales, Net Profit
26.4.201907:31GLOBESanofi delivers strong Q1 2019 business EPS growth of 9.4%..
26.4.201907:30ONESanofi : Forte croissance du BNPA des activités au T1 2019..
26.4.201907:30ONESanofi delivers strong Q1 2019 business EPS growth of 9.4%..
12.4.201918:00ONEInformations relatives au nombre total de droits de vote et..
12.4.201918:00ONEInformation concerning the total number of voting rights and..
10.4.201918:00ONESanofi : Déclaration des transactions sur actions propres
Mehr News über diese Aktie »
Kürzlich von Ihnen besucht
EU
SAN
Sanofi
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

P: V: D:20190616 20:38:55